Cargando…

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients

INTRODUCTION: Circulating microRNAs (miRNAs) are easily accessible and have already proven to be useful as prognostic markers in cancer patients. However, their origin and function in the circulation is still under discussion. In the present study we analyzed changes in the miRNAs in blood plasma of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Summerer, Isolde, Niyazi, Maximilian, Unger, Kristian, Pitea, Adriana, Zangen, Verena, Hess, Julia, Atkinson, Michael J, Belka, Claus, Moertl, Simone, Zitzelsberger, Horst
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3882107/ https://www.ncbi.nlm.nih.gov/pubmed/24373621 http://dx.doi.org/10.1186/1748-717X-8-296

Ejemplares similares

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells
por: Summerer, Isolde, et al.
Publicado: (2015)

Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients
por: Summerer, I, et al.
Publicado: (2015)

A 4-miRNA signature predicts the therapeutic outcome of glioblastoma
por: Niyazi, Maximilian, et al.
Publicado: (2016)

A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy‐treated head and neck squamous cell carcinoma (HNSCC)
por: Wintergerst, Ludmila, et al.
Publicado: (2018)

Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
por: Schnöller, Leon Emanuel, et al.
Publicado: (2022)

MicroRNA-Target Network Inference and Local Network Enrichment Analysis Identify Two microRNA Clusters with Distinct Functions in Head and Neck Squamous Cell Carcinoma
por: Sass, Steffen, et al.
Publicado: (2015)

Definitive chemoradiotherapy in patients with squamous cell cancers of the head and neck - results from an unselected cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Schüttrumpf, Lars, et al.
Publicado: (2020)

Transcriptomic analyses of the radiation response in head and neck squamous cell carcinoma subclones with different radiation sensitivity: time-course gene expression profiles and gene association networks
por: Michna, Agata, et al.
Publicado: (2016)

Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
por: Schoetz, Ulrike, et al.
Publicado: (2021)

Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”
por: Maihoefer, Cornelius, et al.
Publicado: (2018)

Single-center versus multi-center data sets for molecular prognostic modeling: a simulation study
por: Samaga, Daniel, et al.
Publicado: (2020)

DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
por: Unger, Kristian, et al.
Publicado: (2023)

High Expression of EpCAM and Sox2 is a Positive Prognosticator of Clinical Outcome for Head and Neck Carcinoma
por: Baumeister, Philipp, et al.
Publicado: (2018)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
por: De-Colle, Chiara, et al.
Publicado: (2017)

A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
por: Burkart, Sebastian, et al.
Publicado: (2023)

Toxicity of daily low dose cisplatin in radiochemotherapy for locally advanced head and neck cancer
por: Wolff, Hendrik Andreas, et al.
Publicado: (2008)

A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer
por: Schinke, Henrik, et al.
Publicado: (2022)

Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections
por: Kreutzer, Lisa, et al.
Publicado: (2022)

Improved risk stratification in younger IDH wild-type glioblastoma patients by combining a 4-miRNA signature with MGMT promoter methylation status
por: Unger, Kristian, et al.
Publicado: (2020)

DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
por: Tawk, Bouchra, et al.
Publicado: (2023)

Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
por: Orth, Michael, et al.
Publicado: (2021)

Radiochemotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer
por: Schäfer, C, et al.
Publicado: (2006)

Radiochemotherapy fosters a favorable pattern of inflammatory cells in head and neck tumors
por: Distel, Luitpold, et al.
Publicado: (2012)

Prospective Evaluation of Sarcopenia in Head and Neck Cancer Patients Treated with Radiotherapy or Radiochemotherapy
por: Thureau, Sébastien, et al.
Publicado: (2021)

Neck control after definitive radiochemotherapy without planned neck dissection in node-positive head and neck cancers
por: Jang, Na Young, et al.
Publicado: (2012)

Novel modified patient immobilisation device with an integrated coil support system for MR-guided online adaptive radiotherapy in the management of brain and head-and-neck tumours
por: Konnerth, Dinah, et al.
Publicado: (2021)

Counting colonies of clonogenic assays by using densitometric software
por: Niyazi, Maximilian, et al.
Publicado: (2007)

Isobologram analysis of triple therapies
por: Niyazi, Maximilian, et al.
Publicado: (2006)

ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Preliminary insights into the impact of primary radiochemotherapy on the salivary microbiome in head and neck squamous cell carcinoma
por: Kumpitsch, Christina, et al.
Publicado: (2020)

Report on Late Toxicity in Head-and-Neck Tumor Patients with Long Term Survival after Radiochemotherapy
por: Buchberger, Anna Maria Stefanie, et al.
Publicado: (2021)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

Distant metastasis time to event analysis with CNNs in independent head and neck cancer cohorts
por: Lombardo, Elia, et al.
Publicado: (2021)

Combined Radiochemotherapy: Metalloproteinases Revisited
por: Waller, Verena, et al.
Publicado: (2021)

Metformin Protects against Radiation-Induced Acute Effects by Limiting Senescence of Bronchial-Epithelial Cells
por: Hansel, Christine, et al.
Publicado: (2021)

Establishment and Molecular Cytogenetic Characterization of a Cell Culture Model of Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Bauer, Verena L., et al.
Publicado: (2010)

Correction: ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy
por: Guberina, Maja, et al.
Publicado: (2020)

Digital scoring of EpCAM and slug expression as prognostic markers in head and neck squamous cell carcinomas
por: Schinke, Henrik, et al.
Publicado: (2020)

Radiochemotherapy
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_ocehin34fueikq5bcua6gikfh4